CLINICAL TRIAL SUMMARY

MDACC Study No:2005-0956 (clinicaltrials.gov NCT No: NCT00489814)
Title:Prospective evaluation of quality of life after proton therapy for prostate cancer
Principal Investigator:Andrew K. Lee
Treatment Agent:Casodex; Flutamide; Goserelin Acetate; Leuprolide Acetate; Radiation
Study Status:Closed
Study Description:The goal of this research study is to collect information on the side effects
of proton radiation therapy given for the treatment of prostate cancer as well
as the effect of proton therapy on quality of life. Information on your
treatment and how you react to the treatment will be collected. Researchers
will use this information to try to understand how people tolerate proton
radiation therapy for prostate cancer.

Hide details for General InformationGeneral Information

Disease Group:Prostate
Phase of Study:N/A
Treatment Agents:Casodex
Flutamide
Goserelin Acetate
Leuprolide Acetate
Radiation
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:NA
Supported By:N/A
Return Visit:Patients should return to M.D. Anderson at three months after their treatment
and subsequently thereafter at the discretion of the treating physician.
Home Care:N/A


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Andrew K. Lee
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2348
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults